Delivery Order SPE2DB22D1103-SPE2DB24FTFX7
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a specialty pharmaceutical product, with a potential value of $1,583.40 and a performance period through March 8, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract has a potential value of $2,831.10 and a completion date of February 2, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, which has a potential value of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The delivery order, valued at $3,099.36, is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value up to $999,999,999.00 and a performance period through December 31, 2025. This IDC serves...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The order is for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen, with a potential value of $1,070.28 and a completion date of January 29, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for the supply of Trulicity 0.75 mg/0.5 ml pens with a potential value of $1,451.40 and a completion date of February 12, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, with a completion date of February 14, 2024 and a potential value of $1,741.68. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the AmerisourceBergen Corporation, to provide the pharmaceutical product Trulicity 0.75 mg/0.5 mL pen 0.5 mL. The contract has a potential value of $2,144.78 and a completion date of February 7, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the provision of Trulicity 0.75 mg/0.5 ml pens, a specialty pharmaceutical product, with a ceiling value of $6,714.19 and a period of performance through March 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, the prime contractor, for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml pharmaceutical products. The order has a potential value of $2,182.11 and a completion date of March 1, 2024. AmerisourceBergen Drug Corp is a for-profit subsidiary of the parent company Cencora, Inc., doing business as AmerisourceBergen. As a prime contractor, AmerisourceBergen...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, a specialty pharmaceutical product, with a ceiling value of $4,384.02 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) awarded by DLA with a potential...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTFX7Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a specialty pharmaceutical product, with a potential value of $2,713.38 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 3/1/24 |